Criminal Case Not Only Legal Problem For SAC

Jul 26 2013 | 11:26am ET

They pale in comparison to the indictment handed down against SAC Capital Advisors yesterday, but the hedge fund is facing other legal headaches.

SAC has been hit with another lawsuit by investors in Elan Corp., one of the pharmaceutical companies whose shares it is accused of trading illegally. And a longtime legal nemesis appears to hope that the criminal allegations against SAC will revive its own claims against the firm.

The new Elan lawsuit files a similar complaint lodged in December. The latest action, filed this week in Manhattan federal court, alleges that SAC's settlement with the SEC over the Elan trading account for just half of its ill-gotten gains. The investors are seeking $686 million.

SAC also faces a similar lawsuit from investors in Wyeth LLC. The hedge fund and former portfolio manager Mathew Martoma are accused of trading in both companies' securities based on confidential information about drug trials provided by a doctor overseeing them.

Meanwhile, Canadian insurer Fairfax Financial Holdings hopes that the indictment for insider-trading—one of the many misdeed Fairfax alleges against SAC—will revive its own lawsuit against the hedge fund.

Fairfax has waged a bitter seven-year battle with SAC and several other prominent hedge funds, notably Exis Capital, Kynikos Associates and Third Point. The insurer alleges that the hedge funds and brokerage Morgan Keegan conspired to drive down its share price. The claims against SAC were dismissed years ago, and the racketeering lawsuit came to an end in September when a New Jersey state court judge junked the remaining claims against Exis and Morgan Keegan.

Michael Bowe, a lawyer for Fairfax, took to the airwaves yesterday to press his client's case. Bowe suggested to Bloomberg TV that Fairfax's case against SAC mirrors "what the indictment says" and claims that the lawsuit launched the investigation into SAC.

"This is of zero surprise to me, my clients, and, I think, most people who are familiar with how SAC has worked over the years," Bowe said.


In Depth

GSAM's Papagiannis: Liquid Alternatives For The Long Run

Apr 21 2017 | 8:44pm ET

Interest in liquid alternatives cooled a bit last year amid a broad shift in investor...

Lifestyle

Aston Martin Returns To Debt Market As DB11 Drives Turnaround

Mar 31 2017 | 5:21pm ET

James Bond’s preferred carmaker is returning to the public debt markets for the...

Guest Contributor

Debunking Conventional Investment Wisdom (Part II)

Apr 17 2017 | 5:56pm ET

The alternative investment industry is currently replete with buzzwords around data...